• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞衰老的细胞和分子机制及其临床前景。

Cellular and Molecular Mechanisms Involved in Hematopoietic Stem Cell Aging as a Clinical Prospect.

机构信息

Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Oxid Med Cell Longev. 2022 Apr 1;2022:2713483. doi: 10.1155/2022/2713483. eCollection 2022.

DOI:10.1155/2022/2713483
PMID:35401928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8993567/
Abstract

There is a hot topic in stem cell research to investigate the process of hematopoietic stem cell (HSC) aging characterized by decreased self-renewal ability, myeloid-biased differentiation, impaired homing, and other abnormalities related to hematopoietic repair function. It is of crucial importance that HSCs preserve self-renewal and differentiation ability to maintain hematopoiesis under homeostatic states over time. Although HSC numbers increase with age in both mice and humans, this cannot compensate for functional defects of aged HSCs. The underlying mechanisms regarding HSC aging have been studied from various perspectives, but the exact molecular events remain unclear. Several cell-intrinsic and cell-extrinsic factors contribute to HSC aging including DNA damage responses, reactive oxygen species (ROS), altered epigenetic profiling, polarity, metabolic alterations, impaired autophagy, Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, nuclear factor- (NF-) B pathway, mTOR pathway, transforming growth factor-beta (TGF-) pathway, and wingless-related integration site (Wnt) pathway. To determine how deficient HSCs develop during aging, we provide an overview of different hallmarks, age-related signaling pathways, and epigenetic modifications in young and aged HSCs. Knowing how such changes occur and progress will help researchers to develop medications and promote the quality of life for the elderly and possibly alleviate age-associated hematopoietic disorders. The present review is aimed at discussing the latest advancements of HSC aging and the role of HSC-intrinsic factors and related events of a bone marrow niche during HSC aging.

摘要

干细胞研究中有一个热门话题,即研究造血干细胞(HSC)衰老的过程,其特征是自我更新能力下降、向髓系分化、归巢受损以及与造血修复功能相关的其他异常。HSC 保持自我更新和分化能力以在体内平衡状态下随着时间的推移维持造血功能至关重要。尽管在小鼠和人类中,HSC 的数量随年龄增长而增加,但这并不能弥补衰老 HSC 的功能缺陷。人们从多个角度研究了 HSC 衰老的潜在机制,但确切的分子事件仍不清楚。几个细胞内和细胞外因素导致 HSC 衰老,包括 DNA 损伤反应、活性氧(ROS)、表观遗传谱改变、极性、代谢改变、自噬受损、Janus 激酶/信号转导和转录激活因子(JAK/STAT)途径、核因子-(NF-)B 途径、mTOR 途径、转化生长因子-β(TGF-)途径和 Wnt 相关整合位点(Wnt)途径。为了确定在衰老过程中缺陷 HSC 是如何发展的,我们概述了年轻和衰老 HSC 中的不同特征、与年龄相关的信号通路和表观遗传修饰。了解这些变化是如何发生和进展的,将有助于研究人员开发药物,提高老年人的生活质量,并可能缓解与年龄相关的造血障碍。本综述旨在讨论 HSC 衰老的最新进展,以及 HSC 内在因素和 HSC 衰老过程中骨髓龛相关事件的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6154/8993567/07a22efe0692/OMCL2022-2713483.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6154/8993567/48b3f5b60c61/OMCL2022-2713483.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6154/8993567/7e47b9ca9a1c/OMCL2022-2713483.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6154/8993567/00a2a4ebe603/OMCL2022-2713483.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6154/8993567/07a22efe0692/OMCL2022-2713483.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6154/8993567/48b3f5b60c61/OMCL2022-2713483.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6154/8993567/7e47b9ca9a1c/OMCL2022-2713483.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6154/8993567/00a2a4ebe603/OMCL2022-2713483.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6154/8993567/07a22efe0692/OMCL2022-2713483.004.jpg

相似文献

1
Cellular and Molecular Mechanisms Involved in Hematopoietic Stem Cell Aging as a Clinical Prospect.造血干细胞衰老的细胞和分子机制及其临床前景。
Oxid Med Cell Longev. 2022 Apr 1;2022:2713483. doi: 10.1155/2022/2713483. eCollection 2022.
2
Mechanisms and rejuvenation strategies for aged hematopoietic stem cells.衰老造血干细胞的机制和 rejuvenation 策略。
J Hematol Oncol. 2020 Apr 6;13(1):31. doi: 10.1186/s13045-020-00864-8.
3
Cdc42 and aging of hematopoietic stem cells.Cdc42 与造血干细胞衰老。
Curr Opin Hematol. 2013 Jul;20(4):295-300. doi: 10.1097/MOH.0b013e3283615aba.
4
Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis.手牵手:衰老和克隆性造血的内在和外在驱动因素。
Exp Hematol. 2020 Nov;91:1-9. doi: 10.1016/j.exphem.2020.09.197. Epub 2020 Sep 28.
5
Molecular and cellular mechanisms of aging in hematopoietic stem cells and their niches.造血干细胞及其龛位衰老的分子和细胞机制。
J Hematol Oncol. 2020 Nov 23;13(1):157. doi: 10.1186/s13045-020-00994-z.
6
Mitochondrial Contributions to Hematopoietic Stem Cell Aging.线粒体对造血干细胞衰老的贡献。
Int J Mol Sci. 2021 Oct 15;22(20):11117. doi: 10.3390/ijms222011117.
7
Limited rejuvenation of aged hematopoietic stem cells in young bone marrow niche.年轻骨髓龛中衰老造血干细胞的有限再生。
J Exp Med. 2021 Mar 1;218(3). doi: 10.1084/jem.20192283.
8
Epigenetics of hematopoietic stem cell aging.造血干细胞衰老的表观遗传学
Curr Opin Hematol. 2024 Jul 1;31(4):207-216. doi: 10.1097/MOH.0000000000000818. Epub 2024 Apr 12.
9
A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells.造血干细胞衰老的一种新机制:衰老改变了干细胞区室的克隆组成,但不影响单个干细胞。
Blood. 2008 Jun 15;111(12):5553-61. doi: 10.1182/blood-2007-11-123547. Epub 2008 Apr 15.
10
Altered microRNA expression links IL6 and TNF-induced inflammaging with myeloid malignancy in humans and mice.白细胞介素 6(IL6)和肿瘤坏死因子(TNF)诱导的炎症与人类和小鼠髓系恶性肿瘤之间的关联与微小 RNA 表达的改变有关。
Blood. 2020 Jun 18;135(25):2235-2251. doi: 10.1182/blood.2019003105.

引用本文的文献

1
The role of telomeres in leukemic stem cells function.端粒在白血病干细胞功能中的作用。
Regen Ther. 2025 Jul 8;30:351-357. doi: 10.1016/j.reth.2025.06.019. eCollection 2025 Dec.
2
Mesenchymal stem cell-derived exosomes: a novel therapeutic frontier in hematological disorders.间充质干细胞衍生的外泌体:血液系统疾病治疗的新前沿。
Med Oncol. 2025 May 6;42(6):199. doi: 10.1007/s12032-025-02742-0.
3
Protective effect of ginseng extract and total ginsenosides on hematopoietic stem cell damage by inhibiting cell apoptosis and regulating the intestinal microflora.

本文引用的文献

1
Cdc42-Borg4-Septin7 axis regulates HSC polarity and function.Cdc42-Borg4-Septin7 轴调节造血干细胞的极性和功能。
EMBO Rep. 2021 Dec 6;22(12):e52931. doi: 10.15252/embr.202152931. Epub 2021 Oct 18.
2
The comprehensive DNA methylation landscape of hematopoietic stem cell development.造血干细胞发育的全面DNA甲基化图谱。
Cell Discov. 2021 Sep 21;7(1):86. doi: 10.1038/s41421-021-00298-7.
3
Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models.NF-κB 在衰老和与年龄相关疾病中的作用:遗传修饰小鼠模型的启示。
人参提取物及总皂苷通过抑制细胞凋亡和调节肠道菌群对造血干细胞损伤的保护作用。
Int J Mol Med. 2025 Jan;55(1). doi: 10.3892/ijmm.2024.5455. Epub 2024 Nov 8.
4
The Influence of Circulating Exosomes Derived From Younger and Older Donors on Hypoxia-Inducible Factor 1 Alpha Gene Expression and P21 Protein in Cord Blood Hematopoietic Stem Cells.年轻和老年供体来源的循环外泌体对脐血造血干细胞中缺氧诱导因子1α基因表达和P21蛋白的影响。
J Hematol. 2024 Oct;13(5):192-199. doi: 10.14740/jh1291. Epub 2024 Oct 21.
5
The Comparative Effect of Plasma Exosomes of Young and Old People on the Expression of and Genes in Hematopoietic Stem Cells.年轻人与老年人血浆外泌体对造血干细胞中 和 基因表达的比较影响。 (你原文中这两个基因名称没写完整哦)
Indian J Hematol Blood Transfus. 2024 Oct;40(4):647-654. doi: 10.1007/s12288-024-01779-x. Epub 2024 May 1.
6
The role of the hematopoietic stem/progenitor cells-derived extracellular vesicles in hematopoiesis.造血干细胞/祖细胞衍生的细胞外囊泡在造血过程中的作用。
Heliyon. 2024 Jul 24;10(15):e35051. doi: 10.1016/j.heliyon.2024.e35051. eCollection 2024 Aug 15.
7
Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells.探索非病毒方法将 CRISPR-Cas 核糖核蛋白递送至造血干细胞。
Stem Cell Res Ther. 2024 Jul 29;15(1):233. doi: 10.1186/s13287-024-03848-4.
8
Hyperexpression of tumor necrosis factor receptor 2 inhibits differentiation of myeloid-derived suppressor cells by instigating apolarity during ageing.肿瘤坏死因子受体2的过表达通过在衰老过程中引发极性异常来抑制髓源性抑制细胞的分化。
MedComm (2020). 2024 Jun 12;5(6):e605. doi: 10.1002/mco2.605. eCollection 2024 Jun.
9
Long-term hematopoietic transfer of the anti-cancer and lifespan-extending capabilities of a genetically engineered blood system by transplantation of bone marrow mononuclear cells.通过移植骨髓单核细胞,将基因工程血液系统的抗癌和延长寿命的能力进行长期的造血转移。
Elife. 2024 May 16;12:RP88275. doi: 10.7554/eLife.88275.
10
Aging brain: exploring the interplay between bone marrow aging, immunosenescence, and neuroinflammation.衰老大脑:探索骨髓衰老、免疫衰老和神经炎症之间的相互作用。
Front Immunol. 2024 Apr 4;15:1393324. doi: 10.3389/fimmu.2024.1393324. eCollection 2024.
Cells. 2021 Jul 27;10(8):1906. doi: 10.3390/cells10081906.
4
The role of mTOR in age-related diseases.mTOR 在与年龄相关的疾病中的作用。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1679-1693. doi: 10.1080/14756366.2021.1955873.
5
The Role of Rapamycin in Healthspan Extension via the Delay of Organ Aging.雷帕霉素通过延缓器官衰老延长健康寿命的作用。
Ageing Res Rev. 2021 Sep;70:101376. doi: 10.1016/j.arr.2021.101376. Epub 2021 Jun 2.
6
The central role of DNA damage in the ageing process.DNA 损伤在衰老过程中的核心作用。
Nature. 2021 Apr;592(7856):695-703. doi: 10.1038/s41586-021-03307-7. Epub 2021 Apr 28.
7
Autophagy and senescence: Insights from normal and cancer stem cells.自噬与衰老:正常和肿瘤干细胞的新视角。
Adv Cancer Res. 2021;150:147-208. doi: 10.1016/bs.acr.2021.01.005. Epub 2021 Mar 30.
8
Curcumin restores the engraftment capacity of aged hematopoietic stem cells and also reduces PD-1 expression on cytotoxic T cells.姜黄素恢复了老年造血干细胞的植入能力,同时降低了细胞毒性 T 细胞上 PD-1 的表达。
J Tissue Eng Regen Med. 2021 Apr;15(4):388-400. doi: 10.1002/term.3180. Epub 2021 Mar 9.
9
mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate.mTOR 信号作为造血干细胞命运的调节剂。
Stem Cell Rev Rep. 2021 Aug;17(4):1312-1322. doi: 10.1007/s12015-021-10131-z. Epub 2021 Feb 14.
10
Aging of human hematopoietic stem cells is linked to changes in Cdc42 activity.人类造血干细胞的衰老与 Cdc42 活性的变化有关。
Haematologica. 2022 Feb 1;107(2):393-402. doi: 10.3324/haematol.2020.269670.